gentaur logogentaur logo
x

NLRP3-IN-25

NLRP3-IN-25
NLRP3-IN-25

NLRP3-IN-25

Ask for quotation

Ask for quotation
On request
quantity
product details

Catalog number: 804 - HY-155463

Product Category: Business & Industrial > Science & Laboratory

Supplier:

MedChemExpressGentaur

Size: Get quote

Related Products

NLRP3-IN-25

HY-155463

NLRP3-IN-25

NLRP3-IN-25 (compound 32) is an orally available NLRP3 inhibitor with anti-inflammatory activity. NLRP3-IN-25 attenuates renal injury in doxorubicin-induced glomerulonephritis in mice. NLRP3-IN-25 inhibits IL-1β secretion in THP-1 cells with an IC50 of 21 nM[1].

Ask for quotation

IRAK4-IN-25

HY-155518

IRAK4-IN-25

IRAK4-IN-25 (compound 38) is an orally acitve and potent IRAK4 inhibitor (IC50=7.3 nM), with low clearance (Cl=12 mL/min/kg). IRAK4-IN-25 inhibits production of pro-inflammatory cytokines, and shows in vitro safety and ADME profiles. IRAK4-IN-25 can be used for research in inflammatory and autoimmune disorders[1].

Ask for quotation

CDK9-IN-25

HY-155843

CDK9-IN-25

CDK9-IN-25 (compound 4a) is an imidazopyrazine CDK9 inhibitor (IC50: 0.24 μM). CDK9-IN-25 has good affinity to the main protease of COVID-19 and has antiviral activity against human coronavirus 229E (IC50: 63.28 μM)[1].

Ask for quotation

ALK5-IN-25

T62393-50mg

ALK5-IN-25

ALK5-IN-25

Ask for quotation

ALK5-IN-25

T62393-5mg

ALK5-IN-25

ALK5-IN-25

Ask for quotation

AChE-IN-25

T62590-10mg

AChE-IN-25

AChE-IN-25

Ask for quotation

NLRP3-IN-25 (compound 32) is an orally available NLRP3 inhibitor with anti-inflammatory activity. NLRP3-IN-25 attenuates renal injury in doxorubicin-induced glomerulonephritis in mice. NLRP3-IN-25 inhibits IL-1β secretion in THP-1 cells with an IC50 of 21 nM[1].